Pfizer Inc. Sells China Swine Vaccine Unit to Harbin Tian Qing Biotech Application Company for $50 Million
Reuters -- Pfizer Inc (PFE.N), the world's biggest drugmaker, is selling its swine vaccine business in China to Harbin Pharmaceutical Group for $50 million, a source with direct knowledge of the deal said on Monday.